Navigation Links
What About Us? The State of Women's Sexual Health in Question
Date:1/6/2011

SADDLE BROOK, N.J., Jan. 6, 2011 /PRNewswire/ -- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the approval of Fortesta comes just months after the FDA's unanimous rejection of Flibanserin. Dubbed the "pink pill," the female Viagra equivalent, many thought it would be the game changer in closing the gender gap among the sexes.

While Braun Scherl maintains that she credits the men's sexual enhancement category in heightening overall awareness of sexual health, she believes the time has come for culture and network executives to acknowledge women's sexuality.

"Women's sexual well-being is equally important, and they are entitled to sexual pleasure.  Close to half of all women report some form of sexual concern, according to statistics from the American Medical Association," she says.

Yet, decades after the introduction of Viagra and Cialis, she maintains, women still don't have as many options...and culture and advertisers lag behind in giving women's sexual satisfaction the same level of acceptance as men's sexual needs.

Braun Scherl and her business partner, CEO Mary Wallace Jaensch, market Zestra® Essential Arousal Oils™, a clinically proven, hormone-free breakthrough for women documented in two peer reviewed, published studies to boost women's libido,  increase arousal and improve overall satisfaction.  While many health professionals enthusiastically recommend it for patients with dulled desire, advertisers have been reluctant to accept commercials for this topically applied, safe and effective gel.  If they do agree to air Zestra commercials, airtime is often restricted to limited early morning hours.

Meantime, maintains Wallace Jaensch, TV spots for men's sexual erectile dysfunction products are aired on the networks during all hours of the day.  With decreased libido and sexual dissatisfaction so pervasive in women at all stages of their reproductive life, she adds, "It's time women know there are ways they can effectively combat their loss of libido and have great sex effortlessly.  Giving women more options, expanded access to information about these options, and encouraging them to discuss their sexuality openly, are important in closing the sexual satisfaction gap that remains," says Wallace Jaensch.    


'/>"/>
SOURCE Semprae Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
2. Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee
3. Second Thoughts about Fluoride, Reports Scientific American
4. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
5. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
6. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
7. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
8. Joint Commission Urges Patients to Speak Up About Pain
9. ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options
10. ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer
11. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):